SGP (SpyGlass Pharma) Net Margin %: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGP SpyGlass Pharma Inc SGP
12 GF Score
Price $25.07
View Full Analysis

What is SpyGlass Pharma Net Margin %?

SpyGlass Pharma SGP -0.59% 12 Net Margin % is 0.00% as of Jun. 2026. GuruFocus rates SGP with a GF Score™ of 12/100. Among 944 Biotechnology companies, SpyGlass Pharma ranks worse than 105932.1% on this metric.

Net margin is calculated as Net Income divided by its Revenue. SpyGlass Pharma's Net Income for the three months ended in Jun. 2026 was $-19.86 Mil. SpyGlass Pharma's Revenue for the three months ended in Jun. 2026 was $0.00 Mil. Therefore, SpyGlass Pharma's net margin for the quarter that ended in Jun. 2026 was 0.00%.

The historical rank and industry rank for SpyGlass Pharma's Net Margin % or its related term are showing as below:


SGP's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.875
* Ranked among companies with meaningful Net Margin % only.

SpyGlass Pharma  (NAS:SGP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

SpyGlass Pharma Net Margin % Related Terms

SpyGlass Pharma Net Margin % Historical Data

* Premium members only.

The historical data trend for SpyGlass Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SpyGlass Pharma Net Margin % Chart

SpyGlass Pharma Annual Data
Trend Dec23 Dec24 Dec25
Net Margin %
0.00 0.00 0.00

SpyGlass Pharma Quarterly Data
Dec23 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Net Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

SGP vs RIGL, NGNE, OCS: Net Margin % Comparison

For the Biotechnology subindustry, SpyGlass Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SpyGlass Pharma Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SpyGlass Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where SpyGlass Pharma's Net Margin % falls into.


SGP
12GF Score
SpyGlass Pharma Inc SGP
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SpyGlass Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

SpyGlass Pharma's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-39.869/0
= %

SpyGlass Pharma's Net Margin for the quarter that ended in Jun. 2026 is calculated as

Net Margin=Net Income (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-19.864/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
SpyGlass Pharma (SGP) has a Net Margin % of 0.00% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on SpyGlass Pharma and its competitors. According to the industry distribution chart, SpyGlass Pharma ranks #999999 out of 944 companies in the Biotechnology industry.
Is SpyGlass Pharma's Net Margin % too high?
SpyGlass Pharma's current Net Margin % is 0.00%. Based on the distribution chart, SpyGlass Pharma ranks #999999 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, SpyGlass Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does SpyGlass Pharma's Net Margin % compare to RIGL and NGNE?
According to the Biotechnology industry distribution chart, SpyGlass Pharma ranks #999999 out of 944 companies for Net Margin %. This places SpyGlass Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on SpyGlass Pharma and its competitors. SpyGlass Pharma's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SpyGlass Pharma stock overvalued right now?
SpyGlass Pharma (SGP) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. SpyGlass Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For SpyGlass Pharma (SGP), the current Net Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SpyGlass Pharma Business Description

Address 27061 Aliso Creek Road, Suite 100, Aliso Viejo, CA, USA, 92656
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
12GF Score

Get the complete analysis for SGP

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.07
Price